Commit To Purchase Adamas Pharmaceuticals At $12.50, Earn 30.8% Annualized Using Options
July 27, 2016 at 11:48 AM EDT
Investors eyeing a purchase of Adamas Pharmaceuticals Inc (ADMS) stock, but cautious about paying the going market price of $14.55/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $12.50 strike, which has a bid at the time of this writing of $1.50..